IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Saltigo Opens cGMP Plant; Eyes Accelerated Growth

9:38 AM MST | February 25, 2008 | Natasha Alperowicz

Saltigo (Langenfeld, Germany), the wholly owned fine chemical subsidiary of Lanxess, has officially inaugurated a €10-million ($14.5 million), state-of-the-art cGMP custom manufacturing facility at Leverkusen and pledged to invest €50 million through 2009 to position the business for further growth. The four-module, multipurpose cGMP unit, dubbed O10, can produce more than 200 m.t./year of advanced pharmaceutical intermediates (API), registered intermediates, and starting compounds for the pharmaceutical industry. It adds about 25% to Saltigo’s...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa